中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
13期
109-109,110
,共2页
脑梗死%辛伐他汀联合抗栓%临床疗效
腦梗死%辛伐他汀聯閤抗栓%臨床療效
뇌경사%신벌타정연합항전%림상료효
Cerebral infarction%Simvastatin combined with antithrombotic%Clinical curative effect
目的：探讨脑梗死应用辛伐他汀联合抗栓治疗的临床疗效。方法88例脑梗死患者随机分为两组，对照组给予抗栓治疗，观察组加用辛伐他汀治疗。结果观察组患者平均MBI评分为（59.64±3.61）分，其治疗总有效率为95.45%；对照组患者平均MBI评分为（40.55±2.62）分，其治疗总有效率为79.55%，两组差异有统计学意义（P<0.05）。结论辛伐他汀联合抗栓疗法应用于脑梗死治疗中的临床疗效确切。
目的：探討腦梗死應用辛伐他汀聯閤抗栓治療的臨床療效。方法88例腦梗死患者隨機分為兩組，對照組給予抗栓治療，觀察組加用辛伐他汀治療。結果觀察組患者平均MBI評分為（59.64±3.61）分，其治療總有效率為95.45%；對照組患者平均MBI評分為（40.55±2.62）分，其治療總有效率為79.55%，兩組差異有統計學意義（P<0.05）。結論辛伐他汀聯閤抗栓療法應用于腦梗死治療中的臨床療效確切。
목적：탐토뇌경사응용신벌타정연합항전치료적림상료효。방법88례뇌경사환자수궤분위량조，대조조급여항전치료，관찰조가용신벌타정치료。결과관찰조환자평균MBI평분위（59.64±3.61）분，기치료총유효솔위95.45%；대조조환자평균MBI평분위（40.55±2.62）분，기치료총유효솔위79.55%，량조차이유통계학의의（P<0.05）。결론신벌타정연합항전요법응용우뇌경사치료중적림상료효학절。
Objective To investigate the clinical effect of simvastatin combined with antithrombotic therapy in treatment of cerebral infarction. Methods 88 cases of patients with cerebral infarction were randomly divided into two groups. The control group was given antithrombotic therapy while observation group was treated with simvastatin treatment at the basis of control group. Results The average score of MBI was(59.64 ±3.61)and the total effective rate of treatment was 95.45%in observation group. The average MBI score was(40.55±2.62)and the total effective rate of treatment was 79.55%in the control group. There was significant difference between two groups(P<0.05). Conclusion The clinical effect of simvastatin combined with antithrombotic therapy for the treatment of cerebral infarction is effective.
